NCT03844048

An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial

Brief summary

The purpose of this extension study is to provide venetoclax and obtain long-term safety data for subjects who continue to tolerate and derive benefit from receiving venetoclax in ongoing studies.

Interventional study

Status:
Enrolling by invitation
Conditions:
Chronic Lymphocytic Leukemia
Acute Myeloid Leukemia
Multiple Myeloma
Non-Hodgkin's Lymphoma
Acute Lymphoblastic Leukemia
Cancer
Enrollment:
550 patients
Phase:
  • 1
  • 2
  • 3
  • 4
Protocol ID:
M19-388
Allocation:
N/A
Intervention model:
Single Group Assignment
Masking:
None (Open Label)
Purpose:
Treatment

Would you like to know more about this trial?

Yes, please contact me

Eligibility criteria

Participant attributes:
Male and Female

Age:

N/A

Inclusion Criteria:

- Subject has been enrolled and dosed in an ongoing venetoclax study and continues to
tolerate and derive benefit from the study drug.

- Male subject agrees to refrain from sperm donation.

- Female subjects must not be pregnant or breastfeeding.

Exclusion Criteria:

- None.

All the cities where the clinical studies are located

Quebec City - G1J 1Z4
Quebec City - G1J 1Z4

Quebec